Brief: Transgene Gets $15.3 Mln From Sale Of Securities Held For Sale
17/07/2023 20:09
July 17 (Reuters) - Transgene SA TRNG.PA :
* TRANSGENE RECEIVES $15.3 MILLION FROM THE SALE OF
SECURITIES
HELD FOR SALE
* TRANSGENE SA - TRANSGENE REAFFIRMS ITS FINANCIAL
VISIBILITY
UNTIL EARLY 2024
Source text for Eikon: ID:nBw80TMs4a
Further company coverage: TRNG.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Transgene SA
See all newsFrance's Transgene H1 operating income falls on lower tax credit
Transgene jumps 20% on positive cancer vaccine data in early trial
Brief: Transgene & NEC Bio Sign License Agreement To Prepare Next Steps Of Development Of TG4050 In Head & Neck Cancer
Brief: Transgene SA Says Myvac Platform To Initiate Phase 1 Trial In Second Indication In 2026
France's Transgene 2025 net loss widens on higher financial costs